449 related articles for article (PubMed ID: 19084863)
21. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement.
Tsai SM; Wang TN; Ko YC
J Toxicol Environ Health A; 1998 Nov; 55(6):389-404. PubMed ID: 9833970
[TBL] [Abstract][Full Text] [Related]
22. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
[TBL] [Abstract][Full Text] [Related]
23. Experience with primary urethral carcinoma from the blackfoot disease-endemic area of South Taiwan: increased frequency of bulbomembranous adenocarcinoma?
Tsai YS; Yang WH; Tong YC; Lin JS; Pan CC; Tzai TS
Urol Int; 2005; 74(3):229-34. PubMed ID: 15812209
[TBL] [Abstract][Full Text] [Related]
24. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
26. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
27. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan.
Ling MP; Liao CM
Environ Int; 2007 Jan; 33(1):98-107. PubMed ID: 17014909
[TBL] [Abstract][Full Text] [Related]
28. Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan.
Su CC; Lu JL; Tsai KY; Lian IeB
Cancer Causes Control; 2011 Jan; 22(1):101-8. PubMed ID: 21052815
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy.
Resorlu B; Beduk Y; Baltaci S; Ergun G; Talas H
BJU Int; 2009 Feb; 103(4):480-3. PubMed ID: 18990160
[TBL] [Abstract][Full Text] [Related]
30. Does arsenic exposure increase the risk for liver cancer?
Chiu HF; Ho SC; Wang LY; Wu TN; Yang CY
J Toxicol Environ Health A; 2004 Oct; 67(19):1491-500. PubMed ID: 15371225
[TBL] [Abstract][Full Text] [Related]
31. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan.
Chiu HF; Ho SC; Yang CY
Lung Cancer; 2004 Dec; 46(3):265-70. PubMed ID: 15541810
[TBL] [Abstract][Full Text] [Related]
32. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure.
Fernández MI; López JF; Vivaldi B; Coz F
J Urol; 2012 Mar; 187(3):856-61. PubMed ID: 22248521
[TBL] [Abstract][Full Text] [Related]
33. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan.
Chiou HY; Hsueh YM; Liaw KF; Horng SF; Chiang MH; Pu YS; Lin JS; Huang CH; Chen CJ
Cancer Res; 1995 Mar; 55(6):1296-300. PubMed ID: 7882325
[TBL] [Abstract][Full Text] [Related]
34. [Study on distribution of endemic arsenism in China].
Jin Y; Liang C; He G; Cao J
Wei Sheng Yan Jiu; 2003 Nov; 32(6):519-40. PubMed ID: 14963897
[TBL] [Abstract][Full Text] [Related]
35. Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma.
Hsu LI; Chiu AW; Pu YS; Wang YH; Huan SK; Hsiao CH; Hsieh FI; Chen CJ
Toxicol Appl Pharmacol; 2008 Mar; 227(2):229-38. PubMed ID: 18201742
[TBL] [Abstract][Full Text] [Related]
36. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
37. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
38. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
39. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan.
Wang SL; Li WF; Chen CJ; Huang YL; Chen JW; Chang KH; Tsai LY; Chou KM
Sci Total Environ; 2011 Oct; 409(21):4528-35. PubMed ID: 21872294
[TBL] [Abstract][Full Text] [Related]
40. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
Slotnick MJ; Meliker JR; Nriagu JO
J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
